Corden Pharma Brussels SA FDA Record

Summary

FDA record by year

Corden Pharma Brussels SA's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Recent FDA inspections

5 inspections from Apr 2, 2009 to Jan 31, 2020.

NAI

No objectionable conditions or practices were found during the inspection.

VAI

Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.

OAI

Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

Corden Pharma Brussels SA and the FDA: common questions

Has Corden Pharma Brussels SA received an FDA warning letter?

No FDA warning letter addressed to the name "Corden Pharma Brussels SA" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Corden Pharma Brussels SA received an FDA Form 483?

FDA has not published a Form 483 for "Corden Pharma Brussels SA" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Corden Pharma Brussels SA?

The most recent FDA inspection on file ended Jan 31, 2020 at Brussels, Belgium and was classified VAI. FDA has 5 inspections of Corden Pharma Brussels SA on file.